CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia. A prospective study of 405 patients.
D000138:Acidosis / Q000150:complications*; D001264:Athetosis / Q000209:etiology; D002490:Central Nervous System / Q000002:abnormalities*; D002493:Central Nervous System Diseases / Q000209:etiology*; D002675:Child, Preschool; D003072:Cognition Disorders / Q000209:etiology; D004569:Electroencephalography; D004832:Epilepsy, Absence / Q000209:etiology; D004830:Epilepsy, Tonic-Clonic / Q000209:etiology; D004899:Erythroblastosis, Fetal / Q000150:complications*; D005260:Female; D006311:Hearing Disorders / Q000209:etiology; D006801:Humans; D006932:Hyperbilirubinemia / Q000150:complications*; D000860:Hypoxia / Q000150:complications*; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000150:complications*; D007567:Jaundice, Neonatal / Q000150:complications*; D008297:Male; D011247:Pregnancy; D011446:Prospective Studies; D011581:Psychological Tests; D013285:Strabismus / Q000209:etiology